SCHEMBL1664071

SCHEMBL1664071

CCn1cccc1C(=O)Nc1ccc(Nc2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 4/20 0.45
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
PDE7A Q13946 3/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
MAPT P10636 3/20 0.37
TP53 P04637 3/20 0.37
ALDH1A1 P00352 1/20 0.37
MCL1 Q07820 1/20 0.37
EGFR P00533 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
DGAT1 O75907 3/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
TNIK Q9UKE5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665001 0.97 HPGDS (0.44) HPGDSCNR1CNR2PDE7ASMN1; SMN2
SCHEMBL1664073 0.94 HPGDS (0.43) HPGDSSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL1665003 0.94 HPGDS (0.43) HPGDSSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL1664250 0.90 HPGDS (0.46) HPGDSCNR1CNR2PDE7ASMN1; SMN2
SCHEMBL1664088 0.90 HPGDS (0.53) HPGDSCNR1CNR2SMN1; SMN2NPC1
SCHEMBL1664362 0.88 HPGDS (0.56) HPGDSPDE7ASMN1; SMN2NPC1RAB9A
SCHEMBL1664890 0.87 HPGDS (0.43) HPGDSPDE7ASMN1; SMN2NPC1RAB9A
SCHEMBL1664977 0.87 HPGDS (0.44) HPGDSSMN1; SMN2RAB9AMAPTALDH1A1
SCHEMBL1664091 0.86 HPGDS (0.50) HPGDSSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL1664802 0.85 HPGDS (0.55) HPGDSPDE7ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed